Authors:
RAVINDRA NM
ABEDRABBO S
GOKCE OH
TONG FM
PATEL A
VELAGAPUDI R
WILLIAMSON GD
MASZARA WP
Citation: Nm. Ravindra et al., RADIATIVE PROPERTIES OF SIMOX, IEEE transactions on components, packaging, and manufacturing technology. Part A, 21(3), 1998, pp. 441-449
Authors:
VILLALONACALERO M
EDER J
TOPPMEYER D
ALLEN L
VELAGAPUDI R
MYERS M
AMATO A
KAGENHALLET K
RAZVILLAS B
OCONNOR L
FRAM R
KUFE D
VONHOFF D
ROWINSKY E
Citation: M. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF LU79553, A NOVEL BIS-NAPHTHALAMIDE ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 249-249
Authors:
GALLAGHER M
ALLEN SL
STEVENSON J
HILLER K
OMARA V
VELAGAPUDI R
MITCHELL E
VILLALONA M
VANECHO D
JAKIMOWICZ K
ALLEN LF
FISCHKOFF S
ODWYER PJ
Citation: M. Gallagher et al., PHASE-I TRIAL OF THE DOLASTATIN-15 ANALOG LU-103793 (CEMADOTIN) EVERYOTHER DAY FOR 3 DOSES, Annals of oncology, 9, 1998, pp. 386-386
Authors:
VILLALONACALERO MA
BAKER SD
HAMMOND L
AYLESWORTH C
ECKHARDT SG
KRAYNAK M
FRAM R
FISCHKOFF S
VELAGAPUDI R
TOPPMEYER D
RAZVILLAS B
JAKIMOWICZ K
VANHOFF DD
ROWINSKY E
Citation: Ma. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE WATER-SOLUBLE DOLASTATIN-15 ANALOG LU103793 IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2770-2779
Authors:
JOHNSON F
VELAGAPUDI R
HORNBERGER W
WESTON I
LEE J
FAULKNER R
Citation: F. Johnson et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF ANCROD GIVEN AS A SINGLE 12-HOUR INFUSION IN HEALTHY, ADULT SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, p.
Authors:
KUCHER K
MULLERPELTZER H
HORNBERGER W
MAURER R
NOERTERSHEUSER P
DUEBBERS K
VELAGAPUDI R
FAULKNER RD
Citation: K. Kucher et al., DEFIBRINOGENATION EFFECTS OF ANCROD FOLLOWING 3-HOUR INTRAVENOUS-INFUSION DOSES IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 30-30